Compounded Semaglutide Expiration: Shelf Life & Storage Safety

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide expires because the active peptide molecule degrades chemically when exposed to heat, light, and moisture—typically within 30 to 90 days depending on formulation, storage conditions, and the compounding pharmacy's stability data. Unlike some oral medications that remain chemically stable for years, injectable semaglutide is a protein-based compound that begins losing potency as soon as it is mixed.

Knowing why your medication expires matters beyond just convenience: using expired or improperly stored compounded semaglutide may reduce therapeutic benefit, increase unpredictable dosing variability, and complicate your healthcare conversation. PlexusDx emphasizes precision wellness by helping you understand both the science of medication stability and how your genetic profile in GLP-1 and metabolic pathways may influence your response to consistent, properly stored dosing.

How Compounding Pharmacy Stability Affects Shelf Life

Compounded semaglutide is created by a licensed 503A pharmacy that mixes the active pharmaceutical ingredient into a sterile solution. Unlike branded Ozempic or Wegovy, which are manufactured under FDA oversight in large batches with extensive stability testing, compounded medications rely on pharmacy-specific stability data—often more limited because each formulation may vary slightly based on carrier solutions and preservatives used.

The expiration timeline for compounded semaglutide typically ranges from 30 to 90 days from the date of compounding, depending on the specific formulation, storage temperature, and the pharmacy's validated stability data. Your compounding pharmacy should provide written stability information and a clear expiration date on your prescription label, allowing you to plan refills and storage accordingly.

Storage Conditions and Chemical Degradation: A Clinical Framework

Proper storage is essential because semaglutide degrades through hydrolysis and oxidation—chemical processes accelerated by heat, light exposure, and humidity. The active peptide bonds break down, reducing potency and creating compounds of uncertain safety profile. Storing your compounded semaglutide correctly slows degradation and maintains dose consistency throughout its shelf life.

Storage Condition	Impact on Shelf Life & Stability
Refrigeration (2–8°C)	Slows degradation significantly; extends usable shelf life to full 30–90 day window
Room temperature (20–25°C)	Accelerates hydrolysis; reduces shelf life and may shorten window to 14–21 days
Light exposure (ambient or direct sun)	Triggers oxidative breakdown; degrades semaglutide faster even when refrigerated
Humidity or temperature fluctuation	Promotes moisture absorption and crystal formation; compromises potency and safety

Recognizing Signs of Degraded Compounded Medication

Visual inspection before each injection can alert you to potential degradation. Compounded semaglutide should remain clear and colorless; cloudiness, discoloration, visible particles, or crystal formation may indicate chemical breakdown. If you notice any of these changes, do not use the medication and contact your compounding pharmacy and healthcare provider immediately.

Unexpected changes in injection site reactions, delayed onset of effect, or inconsistent appetite suppression after weeks of stable dosing may also signal that your stored medication is degrading. These signs should prompt a conversation with your provider about refill timing, storage review, and whether a fresh batch is needed to ensure consistent therapeutic response.

Who Should Pay Closest Attention to Expiration and Storage: Provider Guidance

Patients starting compounded semaglutide for the first time, those using higher doses, and individuals with genetic predispositions affecting GLP-1 receptor sensitivity should prioritize storage discipline and expiration awareness. Even small reductions in bioavailability due to degradation can meaningfully affect dose response, making it harder to distinguish true therapeutic response from reduced potency.

Your healthcare provider should verify that your compounding pharmacy provides clear written stability data, that you understand your medication's specific expiration date, and that your home storage environment (refrigerator temperature, light exposure, humidity) supports optimal stability. If you travel frequently, keep compounded semaglutide in an insulated cooler with ice packs and request a shorter expiration window for smaller quantities to ensure freshness.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context about your individual genetic predispositions in key GLP-1 signaling pathways—including variants in the GLP1R gene (rs6923761) and GIPR gene (rs1800437)—which can influence how sensitive your system is to the active semaglutide dose. Understanding these predispositions supports a more personalized conversation with your provider about optimal dosing and the importance of maintaining consistent medication potency through proper storage.

The genetic test does not predict your exact medication response, but predispositions in these peptide pathways should be interpreted alongside your expiration and storage practices with a qualified healthcare provider. If your genetic profile suggests higher sensitivity to GLP-1 signaling, even modest reductions in compounded semaglutide potency due to degradation could affect your therapeutic window—making storage compliance particularly relevant for your treatment plan.

By combining knowledge of your genetic predispositions in GLP-1 and metabolic pathways with adherence to proper storage and expiration guidelines, you and your provider can optimize dosing consistency and reduce variables that complicate treatment monitoring. This precision approach helps distinguish true dose response from artifacts caused by medication degradation, supporting more confident dose adjustments and better outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Why does compounded semaglutide expire faster than a typical tablet?

The article explains that semaglutide is a protein-based compound rather than a small stable molecule, and that it begins losing potency as soon as it is mixed. Degradation happens through hydrolysis and oxidation, processes accelerated by heat, light exposure and humidity. Where some oral medications stay chemically stable for years, compounded semaglutide is described as having a window measured in weeks to a few months.

Why does compounded semaglutide have less stability data behind it than branded Ozempic or Wegovy?

The article says branded products are manufactured under FDA oversight in large batches with extensive stability testing, while compounded preparations rely on pharmacy-specific stability data that is often more limited. Each compounded formulation may vary slightly depending on the carrier solutions and preservatives used. That variability is why the shelf-life window differs between pharmacies.

Where does the expiration date on a compounded semaglutide prescription come from?

It comes from the compounding pharmacy's own validated stability data for that specific formulation, according to the article. The pharmacy should supply written stability information along with a clear expiration date printed on the prescription label. The article treats that label and the pharmacy as the authoritative source rather than any general rule of thumb.

What visible changes signal that a compounded product may have degraded?

The article says compounded semaglutide should remain clear and colorless, and that cloudiness, discoloration, visible particles or crystal formation may indicate chemical breakdown. It states that any of these changes should prompt contacting the compounding pharmacy and healthcare provider immediately rather than using the product. Degraded material is described as having an uncertain safety profile.

Can reduced potency be mistaken for a plateau in response?

Yes. The article says delayed onset of effect, unexpected changes in injection site reactions or inconsistent appetite suppression after weeks of stable treatment may signal that stored medication is degrading rather than that the therapy stopped working. It recommends raising this with a provider to review refill timing and whether a fresh batch is warranted. Distinguishing true response from reduced potency is presented as the whole point.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Medvi Semaglutide
• Bioverse Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.